Elodie Bousquet

ORCID: 0000-0001-5926-1385
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Retinal and Optic Conditions
  • Retinal Imaging and Analysis
  • Glaucoma and retinal disorders
  • Ocular Diseases and Behçet’s Syndrome
  • Systemic Lupus Erythematosus Research
  • Retinal Development and Disorders
  • Cerebral Venous Sinus Thrombosis
  • Hormonal Regulation and Hypertension
  • Retinal and Macular Surgery
  • Acute Ischemic Stroke Management
  • Drug-Induced Ocular Toxicity
  • Neuroinflammation and Neurodegeneration Mechanisms
  • melanin and skin pigmentation
  • Mast cells and histamine
  • Biomedical Research and Pathophysiology
  • Ocular Surface and Contact Lens
  • Intraocular Surgery and Lenses
  • Acne and Rosacea Treatments and Effects
  • Sarcoidosis and Beryllium Toxicity Research
  • Saffron Plant Research Studies
  • Drug-Induced Adverse Reactions
  • Ophthalmology and Visual Health Research
  • Methemoglobinemia and Tumor Lysis Syndrome
  • Cardiovascular, Neuropeptides, and Oxidative Stress Research

University of California, Los Angeles
2022-2025

Hôpital Lariboisière
2016-2025

Université Paris Cité
2015-2025

Assistance Publique – Hôpitaux de Paris
2016-2025

Carl Zeiss (Germany)
2024

Bayer (United States)
2024

Novartis (Switzerland)
2024

Advisory Board Company (United States)
2024

Topcon (Netherlands)
2024

Allergan (France)
2024

Central serous chorioretinopathy (CSCR) is a vision-threatening eye disease with no validated treatment and unknown pathogeny. In CSCR, dilation leakage of choroid vessels underneath the retina cause subretinal fluid accumulation retinal detachment. Because glucocorticoids induce aggravate CSCR are known to bind mineralocorticoid receptor (MR), may be related inappropriate MR activation. Our aim was assess effect activation on rat choroidal vasculature translate results patients....

10.1172/jci61427 article EN Journal of Clinical Investigation 2012-06-11

Purpose: To determine the pathoanatomical alteration of ectopic inner foveal layers (EIFL) and its relationship to visual recovery after epiretinal membrane (ERM) peeling surgery. Methods: Clinical charts tracked spectral-domain optical coherence tomography images patients diagnosed with stage 3 4 ERM were reviewed analyzed preoperatively at 6 months postoperatively. Central macular thickness (CMT) EIFL measured these time points. Wilcoxon signed-rank test was used for analysis P < 0.05...

10.1097/iae.0000000000004418 article EN Retina 2025-01-29

Based on experimental data showing that central serous chorioretinopathy could result from overactivation of mineralocorticoid receptor pathway in choroid vessels, the authors studied eplerenone, a antagonist, as potential treatment for chronic chorioretinopathy.This nonrandomized pilot study included 13 patients with at least 4-month duration, treated 25 mg/day oral eplerenone week followed by 50 1 or 3 months. The primary outcome measure was changes macular thickness recorded optical...

10.1097/iae.0b013e318297a07a article EN Retina 2013-05-29

To assess the rate of choroidal neovascularization (CNV) detected by optical coherence tomography angiography (OCTA) in flat irregular pigment epithelium detachment (PED) chronic central serous chorioretinopathy.Data on all consecutive patients with chorioretinopathy who underwent OCTA over a 1-year period were reviewed. The presence PED, which was defined as an elevation retinal allowing visualization distinct Bruch's membrane assessed high-resolution OCT B-scan. Clinical, multimodal...

10.1097/iae.0000000000001580 article EN Retina 2017-03-07

To evaluate the effect of spironolactone, a mineralocorticoid receptor antagonist, for nonresolving central serous chorioretinopathy.This is prospective, randomized, double-blinded, placebo-controlled crossover study. Sixteen eyes 16 patients with chorioretinopathy and persistent subretinal fluid (SRF) at least 3 months were enrolled. Patients randomized to receive either spironolactone 50 mg or placebo once day 30 days, followed by washout period 1 week then crossed over another days. The...

10.1097/iae.0000000000000614 article EN Retina 2015-05-28

In Brief Purpose: Thick choroid (pachychoroid) is associated with central serous chorioretinopathy (CSC), but whether pachychoroid inherited unknown. Methods: a prospective observational study, first- or second-degree relatives (16 individuals) of 5 patients CSC had refraction and visual acuity measurement, fundus examination, nonmydriatic photography, autofluorescence photography. Eyes were graded using the following criteria: 0: normal 1: focal retinal pigment epithelium hyperfluorescence...

10.1097/iae.0000000000000287 article EN Retina 2014-07-22

To study the relationship between location of cystoid spaces and retinal capillary nonperfusion areas in diabetic macular edema (DCME).In this retrospective study, 24 eyes 21 patients with chronic DCME were followed using optical coherence tomography angiography. The density superficial plexus deep was measured AngioAnalytics software all 20 healthy controls. Diabetic improved spontaneously or after treatment 11 eyes.The intraretinal surrounded by capillary-flow void 71% cases 96% cases. had...

10.1097/iae.0000000000001289 article EN Retina 2016-09-09

Fouad, Yousef A. MD; Santina, Ahmad Bousquet, Elodie MD, PhD; Sadda, Srinivas R. Sarraf, David MD Author Information

10.1097/iae.0000000000003798 article EN Retina 2023-03-30

Glucocorticoids are used to treat macular edema, although the mechanisms underlying this effect remain largely unknown. The authors have evaluated in normal and endotoxin-induced uveitis (EIU) rats, effects of dexamethasone (dex) triamcinolone acetonide (TA) on potassium channel Kir4.1 aquaporin-4 (AQP4), two main retinal Müller glial (RMG) channels controlling fluid movement.Clinical as well relatively low doses dex TA were injected vitreous rats evaluate their influence AQP4 expression 24...

10.1167/iovs.11-7675 article EN Investigative Ophthalmology & Visual Science 2011-07-04
Tiphaine Lenfant S. Ben Salah Gaëlle Leroux Elodie Bousquet Véronique Le Guern and 95 more François Chasset Camille Françès Nathalie Morel J. Chezel T. Papo P. Cacoub Luc Mouthon G. Guettrot-Imbert Pascal Cohen Alexis Régent Martine Mauget‐Faÿsse Jean‐Charles Piette M. Jallouli N. Costedoat‐Chalumeau Félix Ackermann Zahir Amoura Bouchra Asli L. Astudillo O. Aumaître C. Bélizna Nadia Belmatoug Olivier Benveniste A. Benyamine Holly Bezanahary Benoı̂t Blanchet Patrick Blanco O Blétry Bahram Bodaghi Pierre Bourgeois B. Brihaye Emmanuel Chatelus Judith Cohen‐Bittan R. Damade Éric Daugas C. Degennes Jean‐François Delfraissy C. Delluc Aurélien Delluc H. Desmurs‐Clavel P. Duhaut Alain Dupuy I. Durieu E A Hang-Korng Olivier Fain Dominique Farge Christian Funck‐Brentano Lionel Galicier Frédérique Gandjbakhch Justine Gellen‐Dautremer Pascale Ghillani‐Dalbin Bertrand Godeau Cécile Goujard C. Grandpeix C. Grangé Lamiae Grimaldi‐Bensouda Loïc Guillevin É. Hachulla Jean-Robert Harlé Julien Haroche Pierre Hausfater Jean‐Sébastien Hulot Jean Jouquan Gilles Kaplanski Homa Keshtmand Jean‐Emmanuel Kahn Mehdi Khellaf Olivier Lambotte David Launay D. Lê Thi Huong Philippe Lechat H. Lévesque Olivier Lidove Frédéric Lioté É. Liozon L Y Kim Matthieu Mahévas K. Mariampillai Xavier Mariette Alexis Mathian K. Mazodier Marc Michel Lucile Musset Rokiya Ngack J. Ninet Éric Oksenhendler Jean‐Luc Pellegrin L. Pérard Olivier Peyr Anne‐Marie Piette Vincent Poindron Jacques Pourrat Fabienne Roux David Saadoun Karim Sacré Sabrinel Sahali

Abstract Objective HCQ is an essential medication in SLE, proven to lengthen survival and reduce flares. Its use, however, limited by its rare but severe ophthalmological complications. Here, we aimed analyse factors associated with retinopathy including blood levels. Methods This case–control study compared SLE patients without retinopathy, defined abnormal results for at least two of the following tests: automated visual fields, spectral-domain optical coherence tomography (SD-OCT),...

10.1093/rheumatology/keaa157 article EN Lara D. Veeken 2020-03-18

Purpose To identify the factors predicting visual and anatomical outcomes in eyes with central serous chorioretinopathy (CSCR) through 12 months. Methods Patients diagnosis of CSCR, either acute or chronic, were included this multicentric, retrospective study. Demographic factors; systemic risk macular thickness (CMT), subfoveal choroidal (SFCT), linear extent ellipsoid zone (EZ) interdigitation damage on optical coherence tomography; details leak fluorescein angiography indocyanine green as...

10.1136/bjophthalmol-2020-317422 article EN British Journal of Ophthalmology 2020-12-07

Targeted drug delivery to the ocular tissues remains a challenge. Biodegradable intraocular implants allow prolonged controlled release of drugs directly into eye. In this study, we evaluated an anterior suprachoroidal polyurethane implant containing dexamethasone dispersions (DX-PUD) as system in rat model endotoxin-induced uveitis (EIU).In vitro was studied using PUD 8%, 20%, and 30% (wt/wt) DX. Cytotoxicity degradation products DX-PUD assessed on human ARPE-19 cells...

10.1167/iovs.15-18127 article EN cc-by-nc-nd Investigative Ophthalmology & Visual Science 2016-04-07

We have previously shown that the eye is a mineralocorticoid-sensitive organ and we now question role of mineralocorticoid receptor (MR) in ocular inflammation. The endotoxin-induced uveitis (EIU), rat model human intraocular inflammation, was induced by systemic administration lipopolysaccharide (LPS). Evaluations were made 6 24 hours after injection aldosterone (simultaneous to LPS injection). Three onset EIU, MR glucocorticoid metabolizing enzyme 11-beta hydroxysteroid dehydrogenase type...

10.1371/journal.pone.0049036 article EN cc-by PLoS ONE 2012-11-09
Coming Soon ...